1. Home
  2. COEP vs NVNI Comparison

COEP vs NVNI Comparison

Compare COEP & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • NVNI
  • Stock Information
  • Founded
  • COEP 2017
  • NVNI 2019
  • Country
  • COEP United States
  • NVNI Brazil
  • Employees
  • COEP N/A
  • NVNI N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • NVNI
  • Sector
  • COEP Health Care
  • NVNI
  • Exchange
  • COEP Nasdaq
  • NVNI Nasdaq
  • Market Cap
  • COEP 27.4M
  • NVNI 31.5M
  • IPO Year
  • COEP N/A
  • NVNI N/A
  • Fundamental
  • Price
  • COEP $9.47
  • NVNI $0.35
  • Analyst Decision
  • COEP
  • NVNI
  • Analyst Count
  • COEP 0
  • NVNI 0
  • Target Price
  • COEP N/A
  • NVNI N/A
  • AVG Volume (30 Days)
  • COEP 37.4K
  • NVNI 1.3M
  • Earning Date
  • COEP 08-15-2025
  • NVNI 08-07-2025
  • Dividend Yield
  • COEP N/A
  • NVNI N/A
  • EPS Growth
  • COEP N/A
  • NVNI N/A
  • EPS
  • COEP N/A
  • NVNI N/A
  • Revenue
  • COEP $62,874.00
  • NVNI $31,250,627.00
  • Revenue This Year
  • COEP N/A
  • NVNI $12.05
  • Revenue Next Year
  • COEP N/A
  • NVNI $15.02
  • P/E Ratio
  • COEP N/A
  • NVNI N/A
  • Revenue Growth
  • COEP N/A
  • NVNI 1491.58
  • 52 Week Low
  • COEP $2.31
  • NVNI $0.14
  • 52 Week High
  • COEP $13.70
  • NVNI $12.19
  • Technical
  • Relative Strength Index (RSI)
  • COEP 62.24
  • NVNI 53.38
  • Support Level
  • COEP $7.25
  • NVNI $0.28
  • Resistance Level
  • COEP $9.90
  • NVNI $0.38
  • Average True Range (ATR)
  • COEP 0.63
  • NVNI 0.03
  • MACD
  • COEP 0.26
  • NVNI 0.01
  • Stochastic Oscillator
  • COEP 85.62
  • NVNI 74.21

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About NVNI Nvni Group Limited

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

Share on Social Networks: